DexCom, Inc. (DXCM)
65.25
+0.40
(+0.62%)
USD |
NASDAQ |
Dec 04, 16:00
65.12
-0.13
(-0.20%)
After-Hours: 20:00
DexCom Market Cap: 25.45B for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 218.05B |
| Eli Lilly & Co. | 907.99B |
| Regeneron Pharmaceuticals, Inc. | 75.97B |
| UnitedHealth Group, Inc. | 302.09B |
| Merck & Co., Inc. | 250.41B |
Market Cap Related Metrics
| PE Ratio | 36.31 |
| PS Ratio | 5.887 |
| PEG Ratio | 4.711 |
| Price to Book Value | 9.335 |
| Price to Free Cash Flow | 25.04 |
| Price | 65.25 |
| Earnings Yield | 2.75% |
| PEGY Ratio | 4.711 |
| Operating PE Ratio | 34.19 |
| Normalized PE Ratio | 36.31 |